SAN DIEGO, CA – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Associated Press and Paraguay’s top television news channel Telefuturo covered the historic news of the government of Paraguay granting its first-ever import permit for Real Scientific Hemp Oil™ (RSHO™) as a prescription medication for refractory epilepsy.
The Associated Press article titled “Paraguay importara aceite de marihuana de Estados Unidos (Parguay imports hemp oil from the United States),” features comments from a spokesman for the Paraguay Government’s National Anti-Drug Secretariat about the country’s decision to allow RSHO™ into the country. The Telefuturo broadcast is titled: “Autorizan importación de aceite de cannabis para uso medicina (Hemp oil authorized for import for medical use.)”
Dr. Stuart Titus, CEO of Medical Marijuana, Inc., said, “We’re humbled and grateful that top media outlets continue to cover these historic events of countries authorizing import permits for RSHO™. It’s exciting to hear about residents who are experiencing the real benefits of cannabidiol (CBD) oil for the very first time. We want everyone around the world to have access to RSHO™, and we gratefully applaud the government of Paraguay for acting so swiftly on behalf of the health and welfare of their people.”
In May 2016, the Paraguay government authorized RSHO™ for import into the country as a prescription medication for refractory epilepsy — making it the third country in Latin America after Brazil and Mexico, along with Puerto Rico in the Caribbean — to approve Medical Marijuana Inc.’s CBD hemp oil for multiple medical indications. Currently, Medical Marijuana, Inc.’s RSHO™ products are shipping to more than 40 countries around the world.
About Medical Marijuana Inc. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500